Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials

Accumulating data support a therapeutic role for mesenchymal stem cell (MSC) therapy; however, there is no consensus on the optimal route of delivery. We tested the hypothesis that the route of MSC delivery influences the reduction in infarct size and improvement in left ventricular ejection fractio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation research Jg. 120; H. 7; S. 1139
Hauptverfasser:	Kanelidis, Anthony J, Premer, Courtney, Lopez, Juan, Balkan, Wayne, Hare, Joshua M
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 31.03.2017
Schlagworte:	Animals Clinical Trials as Topic Humans Injections - adverse effects Injections - methods Mesenchymal Stem Cell Transplantation - adverse effects Mesenchymal Stem Cell Transplantation - methods Mice Myocardial Infarction - therapy Rats Swine cell- and tissue-based therapy meta-analysis heart failure mesenchymal stem cell transplantation myocardial infarction
ISSN:	1524-4571, 1524-4571
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!